Time Pharmaceuticals Limited is preparing to issue its initial public offering (IPO) through the book-building method, and the company’s shares will not be available at the traditional face value of Rs. 100. Following the completion of the institutional bidding process, the cut-off price has been fixed at Rs. 500 per share.

According to the Securities Board of Nepal (SEBON) regulations, general investors will receive a 10% discount on the cut-off price, allowing them to purchase Time Pharmaceuticals' IPO at Rs. 450 per share. The company plans to issue 1,086,500 ordinary shares, representing 20.50% of its issued capital of Rs. 530 million.

Of the total IPO shares, 40% or 434,600 units have already been allocated to qualified institutional investors through the bidding process. The remaining 651,900 shares will be issued to the general public. Investors applying through the public issue will be required to apply for a minimum of 50 shares.

After completing the institutional bidding process, Time Pharmaceuticals will now apply to the Securities Board of Nepal for approval to issue the IPO to the general public.